Surgical Biologics will operate as a wholly owned subsidiary of MiMedx Group. The company’s product portfolio includes the Purion process that follows strict guidelines for allograft processing.
MiMedx projects that 2011 company revenues from the acquisition will be in the range of $7 million.
Read the MiMedx news release on the acquisition.
Read other coverage on orthopedic and spine device acquisitions:
– DJO Acquires Elastic Therapy
– Zimmer Finalizes Acquisition of Beijing Montagne Medical Device Co.
– Hanger Orthopedic Group Completes Acquisition of Accelerated Care Plus
